Schonfeld Strategic Advisors LLC Eagle Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $409,146 - $493,950	-11,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $15,644 - $19,776	388 Added 3.62%	11,100 $463,000
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $446,904 - $549,954	10,712 New	10,712 $500,000
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $415,330 - $620,928	-8,104 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $422,704 - $541,833	8,104 New	8,104 $427,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.